Search Results - "L'Haridon, T."

A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1) by Bonnefoi, H., Grellety, T., Tredan, O., Saghatchian, M., Dalenc, F., Mailliez, A., L'Haridon, T., Cottu, P., Abadie-Lacourtoisie, S., You, B., Mousseau, M., Dauba, J., Del Piano, F., Desmoulins, I., Coussy, F., Madranges, N., Grenier, J., Bidard, F.C., Proudhon, C., MacGrogan, G., Orsini, C., Pulido, M., Gonçalves, A.

“…Several expression array studies identified molecular apocrine breast cancer (BC) as a subtype that expresses androgen receptor (AR) but not estrogen receptor…”
Get full text

Patient preference between Cabazitaxel and Docetaxel for first-line chemotherapy in metastatic castrate-resistant prostate cancer (mCRPC): Results from the CABADOC randomized trial by Fizazi, K., Delva, R., Gravis, G., Baciarello, G., Theodore, C., Gross-Goupil, M., Bompas, E., Joly Lobbedez, F., Tazi, Y., L'Haridon, T., Nguyen Tan Hon, T., Barthelemy, P., Culine, S., Berdah, J-F., Deblock, M., Beuzeboc, P., Fléchon, A., Cheneau, C., Martineau, G., Borget, I.

Get full text

PCN179 - A Cost-Utility Analysis Comparing Two Sequences of Treatment for First-Line Chemotherapy in Metastatic Prostate Cancer (MCRPC): Cabazitaxel Followed by Docetaxel Versus Docetaxel Followed by Cabazitaxel by Schwager, M, Fizazi, K, Zaghdoud, N, Delva, R, Gravis Mescam, G, Baciarello, G, Theodore, C, Gross Goupil, M, Bompas, E, Joly, F, Tazi, Y, L'Haridon, T, N'guyen, T, Barthelemy, P, Culine, S, Berdah, J, Deblock, M, Beuzedoc, P, Flechon, A, Cheneau, C, Martineau, G, Borget, I

Get full text

A Cost-Utility Analysis Comparing Two Sequences of Treatment for First-Line Chemotherapy in Metastatic Prostate Cancer (MCRPC): Cabazitaxel Followed by Docetaxel Versus Docetaxel Followed by Cabazitaxel by Schwager, M, Fizazi, K, Zaghdoud, N, Delva, R, Gravis Mescam, G, Baciarello, G, Theodore, C, Gross Goupil, M, Bompas, E, Joly, F, Tazi, Y, L'Haridon, T, N'guyen, T, Barthelemy, P, Culine, S, Berdah, J, Deblock, M, Beuzedoc, P, Flechon, A, Cheneau, C, Martineau, G, Borget, I

“…OBJECTIVES: Docetaxel and Cabazitaxel are taxane chemotherapy approved in men with mCRPC after they demonstrated improved survival in first and second line…”
Get full text

Abstract OT3-3-04: ALOPREV: first cooling scalp trial for prevention of persisting alopecia after docetaxel for early breast cancer patients by Bourgeois, H, Soulié, P, Lucas, B, Mercier, Blas A, Zannetti, A, Delecroix, V, L'haridon, T, Blot, E, Delaloge, S, Grudé, F

“…Abstract During SABCS 2009, Western France Observatory of Cancer has presented “ALOPERS” results from more than one hundred patients with persisting alopecia…”
Get full text

A Phase Ii Trial of Abiraterone Acetate Plus Prednisone in Patients with Molecular Apocrine (Her2-Negative) Locally Advanced or Metastatic Breast Cancer: a Ucbg Study by Gonçalves, A., Mailliez, A., Dalenc, F., You, B., L'haridon, T., Leheurteur, M., Tredan, O., Ferrero, J., Del Piano, F., Alliot, C., Lucas, B., Dohollou, N., Cottu, P.H., Dauba, J., De Cremoux, P., Pierga, J., Orsini, C., Pulido, M., Macgrogan, G., Bonnefoi, H.

Get full text

410TiPA PHASE II TRIAL OF ABIRATERONE ACETATE PLUS PREDNISONE IN PATIENTS WITH MOLECULAR APOCRINE (HER2-NEGATIVE) LOCALLY ADVANCED OR METASTATIC BREAST CANCER: A UCBG STUDY by Gonçalves, A., Mailliez, A., Dalenc, F., You, B., L'haridon, T., Leheurteur, M., Tredan, O., Ferrero, J., Del Piano, F., Alliot, C., Lucas, B., Dohollou, N., Cottu, P.H., Dauba, J., De Cremoux, P., Pierga, J., Orsini, C., Pulido, M., Macgrogan, G., Bonnefoi, H.

“…Abstract Background: The molecular apocrine breast cancer subset has recently been identified. These tumours are estrogen receptor (ER) negative but are…”
Get full text

P181 WITNESS: Real-world outcomes of Nivolumab (NIVO) + Ipilimumab (IPI) in patients (pts) with previously untreated clear cell advanced Renal Cell Carcinoma (aRCC) in France - 1 year minimum follow-up by Barthélémy, P., Vano, Y-A., Eymard, J-C., Narciso, B., Martin, S., Bigot, P., Chehimi, M., Bennamoun, M., Mouillet, G., Moreira, A., Solub, D., L Haridon, T., Gimel, P., Mahammedi, H., Thiery-Vuillemin, A., Petit, G., Escudier, B., Albigès, L.

Get full text